158 related articles for article (PubMed ID: 19616529)
1. Advantages of the high resolution melting in the detection of BRCA1 or BRCA2 mutation carriers.
Jiménez Ide J; Esteban Cardeñosa E; Palanca Suela S; González EB; Bolufer Gilabert P;
Clin Biochem; 2009 Oct; 42(15):1572-6. PubMed ID: 19616529
[TBL] [Abstract][Full Text] [Related]
2. A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting.
van der Hout AH; van den Ouweland AM; van der Luijt RB; Gille HJ; Bodmer D; Brüggenwirth H; Mulder IM; van der Vlies P; Elfferich P; Huisman MT; ten Berge AM; Kromosoeto J; Jansen RP; van Zon PH; Vriesman T; Arts N; Lange MB; Oosterwijk JC; Meijers-Heijboer H; Ausems MG; Hoogerbrugge N; Verhoef S; Halley DJ; Vos YJ; Hogervorst F; Ligtenberg M; Hofstra RM
Hum Mutat; 2006 Jul; 27(7):654-66. PubMed ID: 16683254
[TBL] [Abstract][Full Text] [Related]
3. Pitfalls and caveats in BRCA sequencing.
Bellosillo B; Tusquets I
Ultrastruct Pathol; 2006; 30(3):229-35. PubMed ID: 16825125
[TBL] [Abstract][Full Text] [Related]
4. Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance.
Chenevix-Trench G; Healey S; Lakhani S; Waring P; Cummings M; Brinkworth R; Deffenbaugh AM; Burbidge LA; Pruss D; Judkins T; Scholl T; Bekessy A; Marsh A; Lovelock P; Wong M; Tesoriero A; Renard H; Southey M; Hopper JL; Yannoukakos K; Brown M; Easton D; Tavtigian SV; Goldgar D; Spurdle AB;
Cancer Res; 2006 Feb; 66(4):2019-27. PubMed ID: 16489001
[TBL] [Abstract][Full Text] [Related]
5. Prediction of BRCA1 and BRCA2 mutation status using post-irradiation assays of lymphoblastoid cell lines is compromised by inter-cell-line phenotypic variability.
Lovelock PK; Wong EM; Sprung CN; Marsh A; Hobson K; French JD; Southey M; Sculley T; Pandeya N; Brown MA; Chenevix-Trench G; Spurdle AB; McKay MJ;
Breast Cancer Res Treat; 2007 Sep; 104(3):257-66. PubMed ID: 17063265
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.
Thomassen M; Hansen TV; Borg A; Lianee HT; Wikman F; Pedersen IS; Bisgaard ML; Nielsen FC; Kruse TA; Gerdes AM
Acta Oncol; 2008; 47(4):772-7. PubMed ID: 18465347
[TBL] [Abstract][Full Text] [Related]
7. Identification of ryanodine receptor 1 single-nucleotide polymorphisms by high-resolution melting using the LightCycler 480 System.
Grievink H; Stowell KM
Anal Biochem; 2008 Mar; 374(2):396-404. PubMed ID: 18082125
[TBL] [Abstract][Full Text] [Related]
8. A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genes.
Hondow HL; Fox SB; Mitchell G; Scott RJ; Beshay V; Wong SQ; ; Dobrovic A
BMC Cancer; 2011 Jun; 11():265. PubMed ID: 21702907
[TBL] [Abstract][Full Text] [Related]
9. Molecular and in silico analysis of BRCA1 and BRCA2 variants.
Tommasi S; Pilato B; Pinto R; Monaco A; Bruno M; Campana M; Digennaro M; Schittulli F; Lacalamita R; Paradiso A
Mutat Res; 2008 Sep; 644(1-2):64-70. PubMed ID: 18694767
[TBL] [Abstract][Full Text] [Related]
10. Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene.
Bonnet C; Krieger S; Vezain M; Rousselin A; Tournier I; Martins A; Berthet P; Chevrier A; Dugast C; Layet V; Rossi A; Lidereau R; Frébourg T; Hardouin A; Tosi M
J Med Genet; 2008 Jul; 45(7):438-46. PubMed ID: 18424508
[TBL] [Abstract][Full Text] [Related]
11. Patients with an unclassified genetic variant in the BRCA1 or BRCA2 genes show different clinical features from those with a mutation.
Gómez-García EB; Ambergen T; Blok MJ; van den Wijngaard A
J Clin Oncol; 2005 Apr; 23(10):2185-90. PubMed ID: 15800311
[TBL] [Abstract][Full Text] [Related]
12. Disease family history and modification of breast cancer risk in common BRCA2 variants.
Seymour IJ; Casadei S; Zampiga V; Rosato S; Danesi R; Falcini F; Strada M; Morini N; Naldoni C; Paradiso A; Tommasi S; Schittulli F; Amadori D; Calistri D
Oncol Rep; 2008 Mar; 19(3):783-6. PubMed ID: 18288416
[TBL] [Abstract][Full Text] [Related]
13. Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab Investigators.
Spurdle AB; Lakhani SR; Healey S; Parry S; Da Silva LM; Brinkworth R; Hopper JL; Brown MA; Babikyan D; Chenevix-Trench G; Tavtigian SV; Goldgar DE;
J Clin Oncol; 2008 Apr; 26(10):1657-63. PubMed ID: 18375895
[TBL] [Abstract][Full Text] [Related]
14. Validation of high-resolution DNA melting analysis for mutation scanning of the LMNA gene.
Millat G; Chanavat V; Julia S; Crehalet H; Bouvagnet P; Rousson R
Clin Biochem; 2009 Jun; 42(9):892-8. PubMed ID: 19318026
[TBL] [Abstract][Full Text] [Related]
15. Assessing high-resolution melt curve analysis for accurate detection of gene variants in complex DNA fragments.
Tindall EA; Petersen DC; Woodbridge P; Schipany K; Hayes VM
Hum Mutat; 2009 Jun; 30(6):876-83. PubMed ID: 19280649
[TBL] [Abstract][Full Text] [Related]
16. High-resolution melting analysis for rapid screening of BRCA1 and BRCA2 Spanish mutations.
de Juan I; Esteban E; Palanca S; Barragán E; Bolufer P
Breast Cancer Res Treat; 2009 May; 115(2):405-14. PubMed ID: 18528753
[TBL] [Abstract][Full Text] [Related]
17. High resolution melting for mutation scanning of TP53 exons 5-8.
Krypuy M; Ahmed AA; Etemadmoghadam D; Hyland SJ; ; DeFazio A; Fox SB; Brenton JD; Bowtell DD; Dobrovic A
BMC Cancer; 2007 Aug; 7():168. PubMed ID: 17764544
[TBL] [Abstract][Full Text] [Related]
18. Rapid detection of carriers with BRCA1 and BRCA2 mutations using high resolution melting analysis.
Takano EA; Mitchell G; Fox SB; Dobrovic A
BMC Cancer; 2008 Feb; 8():59. PubMed ID: 18298804
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation.
Willems AJ; Dawson SJ; Samaratunga H; De Luca A; Antill YC; Hopper JL; Thorne HJ;
Clin Cancer Res; 2008 May; 14(10):2953-61. PubMed ID: 18445692
[TBL] [Abstract][Full Text] [Related]
20. Reliability of DHPLC in mutational screening of beta-globin (HBB) alleles.
Colosimo A; Guida V; De Luca A; Cappabianca MP; Bianco I; Palka G; Dallapiccola B
Hum Mutat; 2002 Mar; 19(3):287-95. PubMed ID: 11857746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
